Keywords: gilead, cuts, hiv/aids, drug, price, africa, sciences

Gilead cuts HIV/AIDS drug price for Africa

Article | 06 January 2003

Print This

Gilead Sciences has announced that it will sell its HIV/AIDS drug Viread(tenofovir disoproxil fumarate) at no profit throughout ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in